References
1. Emery AE. Population frequencies of
inherited neuromuscular diseases–a world survey. Neuromuscular
disorders : NMD . 1991;1:19-29.
2. Parsons EP, Bradley DM and Clarke
AJ. Newborn screening for Duchenne muscular dystrophy. Archives of
disease in childhood . 2003;88:91-2.
3. McKusick VA. Mendelian Inheritance
in Man and its online version, OMIM. American journal of human
genetics . 2007;80:588-604.
4. Romitti PA, Zhu Y, Puzhankara S,
James KA, Nabukera SK, Zamba GK, Ciafaloni E, Cunniff C, Druschel CM,
Mathews KD, Matthews DJ, Meaney FJ, Andrews JG, Conway KM, Fox DJ,
Street N, Adams MM, Bolen J and STARnet MD. Prevalence of Duchenne and
Becker muscular dystrophies in the United States. Pediatrics .
2015;135:513-21.
5. Fairclough RJ, Bareja A and Davies
KE. Progress in therapy for Duchenne muscular dystrophy.Experimental physiology . 2011;96:1101-13.
6. Zhou L and Lu H. Targeting fibrosis
in Duchenne muscular dystrophy. Journal of neuropathology and
experimental neurology . 2010;69:771-6.
7. Bonilla E, Samitt CE, Miranda AF,
Hays AP, Salviati G, DiMauro S, Kunkel LM, Hoffman EP and Rowland LP.
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell
surface. Cell . 1988;54:447-52.
8. Perloff JK, de Leon AC, Jr. and
O’Doherty D. The cardiomyopathy of progressive muscular dystrophy.Circulation . 1966;33:625-48.
9. Wells DJ, Ferrer A and Wells KE.
Immunological hurdles in the path to gene therapy for Duchenne muscular
dystrophy. Expert reviews in molecular medicine . 2002;4:1-23.
10. Chamberlain JS. Gene therapy of
muscular dystrophy. Human molecular genetics . 2002;11:2355-62.
11. Roberts M and Dickson G. The
future of Duchenne muscular dystrophy gene therapy: shrinking the
dystrophin gene. Current opinion in molecular therapeutics .
2002;4:343-8.
12. Harper SQ, Hauser MA, DelloRusso
C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt
JF, Brooks SV and Chamberlain JS. Modular flexibility of dystrophin:
implications for gene therapy of Duchenne muscular dystrophy.Nature medicine . 2002;8:253-61.
13. Matsuo M. Duchenne and Becker
muscular dystrophy: from gene diagnosis to molecular therapy.IUBMB life . 2002;53:147-52.
14. Duan D. Dystrophin Gene
Replacement and Gene Repair Therapy for Duchenne Muscular Dystrophy in
2016: An Interview. Human gene therapy Clinical development .
2016;27:9-18.
15. Duan D. Dystrophin gene
replacement and gene repair therapy for Duchenne muscular dystrophy in
2016. Human gene therapy Clinical development . 2016.
16. de Kermadec JM, Becane HM,
Chenard A, Tertrain F and Weiss Y. Prevalence of left ventricular
systolic dysfunction in Duchenne muscular dystrophy: an
echocardiographic study. American heart journal . 1994;127:618-23.
17. Angermann C, Spes C and Pongratz
D. [Cardiac manifestation of progressive muscular dystrophy of the
Duchenne type]. Zeitschrift fur Kardiologie . 1986;75:542-51.
18. Manzur AY, Kinali M and Muntoni
F. Update on the management of Duchenne muscular dystrophy.Archives of disease in childhood . 2008;93:986-90.
19. Nigro G, Comi LI, Politano L and
Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne
muscular dystrophy. Int J Cardiol . 1990;26:271-7.
20. Mendell JR, Moxley RT, Griggs RC,
Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence
J and et al. Randomized, double-blind six-month trial of prednisone in
Duchenne’s muscular dystrophy. The New England journal of
medicine . 1989;320:1592-7.
21. Bushby K, Muntoni F, Urtizberea
A, Hughes R and Griggs R. Report on the 124th ENMC International
Workshop. Treatment of Duchenne muscular dystrophy; defining the gold
standards of management in the use of corticosteroids. 2-4 April 2004,
Naarden, The Netherlands. Neuromuscular disorders : NMD .
2004;14:526-34.
22. Merlini L, Gennari M, Malaspina
E, Cecconi I, Armaroli A, Gnudi S, Talim B, Ferlini A, Cicognani A and
Franzoni E. Early corticosteroid treatment in 4 Duchenne muscular
dystrophy patients: 14-year follow-up. Muscle & nerve .
2012;45:796-802.
23. Markham LW, Spicer RL, Khoury PR,
Wong BL, Mathews KD and Cripe LH. Steroid therapy and cardiac function
in Duchenne muscular dystrophy. Pediatr Cardiol . 2005;26:768-71.
24. Mehmood M, Hor KN, Al-Khalidi HR,
Benson DW, Jefferies JL, Taylor MD, Egnaczyk GF, Raman SV, Basu SK,
Cripe LH, Germann J and Mazur W. Comparison of right and left
ventricular function and size in Duchenne muscular dystrophy. Eur
J Radiol . 2015;84:1938-42.
25. Eagle M, Baudouin SV, Chandler C,
Giddings DR, Bullock R and Bushby K. Survival in Duchenne muscular
dystrophy: improvements in life expectancy since 1967 and the impact of
home nocturnal ventilation. Neuromuscul Disord . 2002;12:926-9.
26. Bushby K, Finkel R, Birnkrant DJ,
Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S,
Poysky J, Shapiro F, Tomezsko J and Constantin C. Diagnosis and
management of Duchenne muscular dystrophy, part 1: diagnosis, and
pharmacological and psychosocial management. Lancet Neurol .
2010;9:77-93.
27. Bushby K, Finkel R, Birnkrant DJ,
Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S,
Poysky J, Shapiro F, Tomezsko J and Constantin C. Diagnosis and
management of Duchenne muscular dystrophy, part 2: implementation of
multidisciplinary care. Lancet Neurol . 2010;9:177-89.
28. Simonds AK, Muntoni F, Heather S
and Fielding S. Impact of nasal ventilation on survival in hypercapnic
Duchenne muscular dystrophy. Thorax . 1998;53:949-52.
29. Kieny P, Chollet S, Delalande P,
Le Fort M, Magot A, Pereon Y and Perrouin Verbe B. Evolution of life
expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine
de Kepper centre between 1981 and 2011. Ann Phys Rehabil Med .
2013;56:443-54.
30. Hor KN, Gottliebson WM, Carson C,
Wash E, Cnota J, Fleck R, Wansapura J, Klimeczek P, Al-Khalidi HR, Chung
ES, Benson DW and Mazur W. Comparison of magnetic resonance feature
tracking for strain calculation with harmonic phase imaging analysis.JACC Cardiovasc Imaging . 2010;3:144-51.
31. Tran D, Kamani AA, Lessoway VA,
Peterson C, Hor KW and Rohling RN. Preinsertion paramedian ultrasound
guidance for epidural anesthesia. Anesth Analg . 2009;109:661-7.
32. Hor KN, Wansapura J, Markham LW,
Mazur W, Cripe LH, Fleck R, Benson DW and Gottliebson WM.
Circumferential strain analysis identifies strata of cardiomyopathy in
Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.J Am Coll Cardiol . 2009;53:1204-10.
33. Hor KN, Taylor MD, Al-Khalidi HR,
Cripe LH, Raman SV, Jefferies JL, O’Donnell R, Benson DW and Mazur W.
Prevalence and distribution of late gadolinium enhancement in a large
population of patients with Duchenne muscular dystrophy: effect of age
and left ventricular systolic function. J Cardiovasc Magn R .
2013;15.
34. Soslow JH, Xu M, Slaughter JC,
Stanley M, Crum K, Markham LW and Parra DA. Evaluation of
Echocardiographic Measures of Left Ventricular Function in Patients with
Duchenne Muscular Dystrophy: Assessment of Reproducibility and
Comparison to Cardiac Magnetic Resonance Imaging. J Am Soc
Echocardiogr . 2016.
35. Buddhe S, Lewin M, Olson A,
Ferguson M and Soriano BD. Comparison of left ventricular function
assessment between echocardiography and MRI in Duchenne muscular
dystrophy. Pediatric radiology . 2016;46:1399-408.
36. Mendell JR and Lloyd-Puryear M.
Report of MDA muscle disease symposium on newborn screening for Duchenne
muscular dystrophy. Muscle Nerve . 2013;48:21-6.
37. Hor KN, Taylor MD, Al-Khalidi HR,
Cripe LH, Raman SV, Jefferies JL, O’Donnell R, Benson DW and Mazur W.
Prevalence and distribution of late gadolinium enhancement in a large
population of patients with Duchenne muscular dystrophy: effect of age
and left ventricular systolic function. J Cardiovasc Magn Reson .
2013;15:107.
38. Ryan TD, Taylor MD, Mazur W,
Cripe LH, Pratt J, King EC, Lao K, Grenier MA, Jefferies JL, Benson DW
and Hor KN. Abnormal circumferential strain is present in young Duchenne
muscular dystrophy patients. Pediatr Cardiol . 2013;34:1159-65.
39. D’Amario D, Amodeo A, Adorisio R,
Tiziano FD, Leone AM, Perri G, Bruno P, Massetti M, Ferlini A, Pane M,
Niccoli G, Porto I, D’Angelo GA, Borovac JA, Mercuri E and Crea F. A
current approach to heart failure in Duchenne muscular dystrophy.Heart . 2017;103:1770-1779.
40. Moriuchi T, Kagawa N, Mukoyama M
and Hizawa K. Autopsy analyses of the muscular dystrophies. The
Tokushima journal of experimental medicine . 1993;40:83-93.
41. Basset O, Boittin FX, Cognard C,
Constantin B and Ruegg UT. Bcl-2 overexpression prevents calcium
overload and subsequent apoptosis in dystrophic myotubes. The
Biochemical journal . 2006;395:267-76.
42. Constantin B, Sebille S and
Cognard C. New insights in the regulation of calcium transfers by muscle
dystrophin-based cytoskeleton: implications in DMD. Journal of
muscle research and cell motility . 2006;27:375-86.
43. Schreiber A, Smith WL, Ionasescu
V, Zellweger H, Franken EA, Dunn V and Ehrhardt J. Magnetic resonance
imaging of children with Duchenne muscular dystrophy. Pediatric
radiology . 1987;17:495-7.
44. Kim RJ, Chen EL, Lima JA and Judd
RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and
reflect the extent and severity of myocardial injury after acute
reperfused infarction. Circulation . 1996;94:3318-26.
45. Kim RJ, Fieno DS, Parrish TB,
Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ and Judd RM.
Relationship of MRI delayed contrast enhancement to irreversible injury,
infarct age, and contractile function. Circulation .
1999;100:1992-2002.
46. Kim RJ and Manning WJ. Viability
assessment by delayed enhancement cardiovascular magnetic resonance:
will low-dose dobutamine dull the shine? Circulation .
2004;109:2476-9.
47. Kim RJ, Shah DJ and Judd RM. How
we perform delayed enhancement imaging. Journal of cardiovascular
magnetic resonance : official journal of the Society for Cardiovascular
Magnetic Resonance . 2003;5:505-14.
48. Hor KN, Kissoon N, Mazur W, Gupta
R, Ittenbach RF, Al-Khalidi HR, Cripe LH, Raman SV, Puchalski MD,
Gottliebson WM and Benson DW. Regional Circumferential Strain is a
Biomarker for Disease Severity in Duchenne Muscular Dystrophy Heart
Disease: A Cross-Sectional Study. Pediatr Cardiol .
2015;36:111-119.
49. Hor KN, Mazur W, Taylor MD,
Al-Khalidi HR, Cripe LH, Jefferies JL, Raman SV, Chung ES, Kinnett KJ,
Williams K, Gottliebson WM and Benson DW. Effects of steroids and
angiotensin converting enzyme inhibition on circumferential strain in
boys with Duchenne muscular dystrophy: a cross-sectional and
longitudinal study utilizing cardiovascular magnetic resonance. J
Cardiovasc Magn Reson . 2011;13:60.
50. Puchalski MD, Williams RV,
Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E and Gottliebson
WM. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne
muscular dystrophy? International Journal of Cardiovascular
Imaging . 2009;25:57-63.
51. Silva MC, Meira ZM, Gurgel
Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM,
Ferreira Rde A, Zatz M and Rochitte CE. Myocardial delayed enhancement
by magnetic resonance imaging in patients with muscular dystrophy.Journal of the American College of Cardiology . 2007;49:1874-9.
52. Perloff JK, Henze E and Schelbert
HR. Alterations in regional myocardial metabolism, perfusion, and wall
motion in Duchenne muscular dystrophy studied by radionuclide imaging.Circulation . 1984;69:33-42.
53. Ashford MW, Jr., Liu W, Lin SJ,
Abraszewski P, Caruthers SD, Connolly AM, Yu X and Wickline SA. Occult
cardiac contractile dysfunction in dystrophin-deficient children
revealed by cardiac magnetic resonance strain imaging.Circulation . 2005;112:2462-7.
54. Hor KN, Wansapura J, Markham LW,
Mazur W, Cripe LH, Fleck R, Benson W and Gottliebson WM. Circumferential
Strain Analysis Identifies Strata of Cardiomyopathy in Duchenne Muscular
Dystrophy A Cardiac Magnetic Resonance Tagging Study. J Am Coll
Cardiol . 2009;53:1204-1210.
55. Hagenbuch SC, Gottliebson WM,
Wansapura J, Mazur W, Fleck R, Benson DW and Hor KN. Detection of
Progressive Cardiac Dysfunction by Serial Evaluation of Circumferential
Strain in Patients With Duchenne Muscular Dystrophy. Am J
Cardiol . 2010;105:1451-1455.
56. Menon SC, Etheridge SP, Liesemer
KN, Williams RV, Bardsley T, Heywood MC and Puchalski MD. Predictive
value of myocardial delayed enhancement in Duchenne muscular dystrophy.Pediatr Cardiol . 2014;35:1279-85.
57. McMurray JJ. Clinical practice.
Systolic heart failure. N Engl J Med . 2010;362:228-38.
58. Yancy CW, Jessup M, Bozkurt B,
Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T,
Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE,
McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW,
Tang WHW, Tsai EJ and Wilkoff BL. 2013 ACCF/AHA Guideline for the
Management of Heart Failure A Report of the American College of
Cardiology Foundation/American Heart Association Task Force on Practice
Guidelines. Circulation . 2013;128:E240-E327.
59. McMurray JJ, Adamopoulos S, Anker
SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C,
Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko
A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic
P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force
for the D, Treatment of A, Chronic Heart Failure of the European Society
of C, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R,
Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P,
McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA,
Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U,
Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P,
Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B,
Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT,
Ponikowski P and Guidelines ESCCfP. ESC guidelines for the diagnosis and
treatment of acute and chronic heart failure 2012: The Task Force for
the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of
the European Society of Cardiology. Developed in collaboration with the
Heart Failure Association (HFA) of the ESC. Eur J Heart Fail .
2012;14:803-69.
60. Nagai T and Anzai T. [NYHA
functional classification and AHA/ACC Stages for heart failure
management]. Nihon Rinsho . 2016;74 Suppl 6:340-4.
61. Scrutinio D, Lagioia R, Ricci A,
Clemente M, Boni L and Rizzon P. Prediction of Mortality in Mild to
Moderately Symptomatic Patients with Left-Ventricular Dysfunction - the
Role of the New-York-Heart-Association Classification, Cardiopulmonary
Exercise Testing, 2-Dimensional Echocardiography and Holter Monitoring.European Heart Journal . 1994;15:1089-1095.
62. Yancy CW, Jessup M, Bozkurt B,
Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T,
Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE,
McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW,
Tang WHW, Tsai EJ, Wilkoff BL, Anderson JL, Jacobs AK, Halperin JL,
Albert NM, Bozkurt B, Brindis RG, Creager MA, Curtis LH, DeMets D,
Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Pressler SJ,
Sellke FW, Shen WK, Stevenson WG and Yancy CW. 2013 ACCF/AHA Guideline
for the Management of Heart Failure: Executive Summary A Report of the
American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines. Circulation .
2013;128:1810-1852.
63. Rorth R, Jhund PS, Yilmaz MB,
Kristensen SL, Welsh P, Desai AS, Kober L, Prescott MF, Rouleau JL,
Solomon SD, Swedberg K, Zile MR, Packer M and McMurray JJV. Comparison
of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection
Fraction. Circ-Heart Fail . 2020;13.
64. Buddhe S, Cripe L,
Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP,
Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR and Olson AK.
Cardiac Management of the Patient With Duchenne Muscular Dystrophy.Pediatrics . 2018;142:S72-S81.
65. Hor KN, Mah ML, Johnston P, Cripe
TP and Cripe LH. Advances in the diagnosis and management of
cardiomyopathy in Duchenne muscular dystrophy. Neuromuscul
Disord . 2018;28:711-716.
66. Feingold B, Mahle WT, Auerbach S,
Clemens P, Domenighetti AA, Jefferies JL, Judge DP, Lal AK, Markham LW,
Parks WJ, Tsuda T, Wang PJ, Yoo SJ, American Heart Association Pediatric
Heart Failure Committee of the Council on Cardiovascular Disease in the
Y, Council on Clinical C, Council on Cardiovascular R, Intervention,
Council on Functional G, Translational B and Stroke C. Management of
Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific
Statement From the American Heart Association. Circulation .
2017;136:e200-e231.
67. Birnkrant DJ, Bushby K, Bann CM,
Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S,
Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM and Group DMDCCW.
Diagnosis and management of Duchenne muscular dystrophy, part 2:
respiratory, cardiac, bone health, and orthopaedic management.Lancet Neurol . 2018;17:347-361.
68. Connuck DM, Sleeper LA, Colan SD,
Cox GF, Towbin JA, Lowe AM, Wilkinson JD, Orav EJ, Cuniberti L, Salbert
BA, Lipshultz SE and Pediatric Cardiomyopathy Registry Study G.
Characteristics and outcomes of cardiomyopathy in children with Duchenne
or Becker muscular dystrophy: a comparative study from the Pediatric
Cardiomyopathy Registry. Am Heart J . 2008;155:998-1005.
69. Giglio V, Pasceri V, Messano L,
Mangiola F, Pasquini L, Dello Russo A, Damiani A, Mirabella M, Galluzzi
G, Tonali P and Ricci E. Ultrasound tissue characterization detects
preclinical myocardial structural changes in children affected by
Duchenne muscular dystrophy. J Am Coll Cardiol . 2003;42:309-16.
70. Sasaki K, Sakata K, Kachi E,
Hirata S, Ishihara T and Ishikawa K. Sequential changes in cardiac
structure and function in patients with Duchenne type muscular
dystrophy: a two-dimensional echocardiographic study. American
heart journal . 1998;135:937-44.
71. Danilowicz D, Rutkowski M, Myung
D and Schively D. Echocardiography in duchenne muscular dystrophy.Muscle & nerve . 1980;3:298-303.
72. Brunklaus A, Parish E, Muntoni F,
Scuplak S, Tucker SK, Fenton M, Hughes ML and Manzur AY. The value of
cardiac MRI versus echocardiography in the pre-operative assessment of
patients with Duchenne muscular dystrophy. European journal of
paediatric neurology : EJPN : official journal of the European
Paediatric Neurology Society . 2015;19:395-401.
73. Hor KN, Kissoon N, Mazur W, Gupta
R, Ittenbach RF, Al-Khalidi HR, Cripe LH, Raman SV, Puchalski MD,
Gottliebson WM and Benson DW. Regional circumferential strain is a
biomarker for disease severity in duchenne muscular dystrophy heart
disease: a cross-sectional study. Pediatr Cardiol . 2015;36:111-9.
74. Pennell DJ, Sechtem UP, Higgins
CB, Manning WJ, Pohost GM, Rademakers FE, van Rossum AC, Shaw LJ, Yucel
EK, European Society of c and Soceity for Cardiovascular Magnetic R.
Clinical indications for cardiovascular magnetic resonance (CMR):
Consensus Panel report. J Cardiovasc Magn Reson . 2004;6:727-65.
75. Grothues F, Smith G, Moon J,
Bellenger N, Collins P, Klein H and Pennell D. Comparison of interstudy
reproducibility of cardiovascular magnetic resonance with
two-dimensional echocardiography in normal subjects and in patients with
heart failure or left ventricular hypertrophy. Am J Cardiol .
2002;90:29-34.
76. Ferreira VM, Piechnik SK, Robson
MD, Neubauer S and Karamitsos TD. Myocardial tissue characterization by
magnetic resonance imaging: novel applications of T1 and T2 mapping.J Thorac Imaging . 2014;29:147-54.
77. Osman NF and Prince JL.
Regenerating MR tagged images using harmonic phase (HARP) methods.IEEE transactions on bio-medical engineering . 2004;51:1428-33.
78. Earls JP, Ho VB, Foo TK, Castillo
E and Flamm SD. Cardiac MRI: recent progress and continued challenges.J Magn Reson Imaging . 2002;16:111-27.
79. Tandon A, Villa CR, Hor KN,
Jefferies JL, Gao Z, Towbin JA, Wong BL, Mazur W, Fleck RJ, Sticka JJ,
Benson DW and Taylor MD. Myocardial fibrosis burden predicts left
ventricular ejection fraction and is associated with age and steroid
treatment duration in duchenne muscular dystrophy. J Am Heart
Assoc . 2015;4.
80. Puchalski MD, Williams RV,
Askovich B, Sower CT, Hor KH, Su JT, Pack N, Dibella E and Gottliebson
WM. Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne
muscular dystrophy? Int J Cardiovasc Imaging . 2009;25:57-63.
81. D’Amario D, Amodeo A, Adorisio R,
Tiziano FD, Leone AM, Perri G, Bruno P, Massetti M, Ferlini A, Pane M,
Niccoli G, Porto I, D’Angelo GA, Borovac JA, Mercuri E and Crea F. A
current approach to heart failure in Duchenne muscular dystrophy.Heart . 2017;103:1770-+.
82. Hagenbuch SC, Gottliebson WM,
Wansapura J, Mazur W, Fleck R, Benson DW and Hor KN. Detection of
progressive cardiac dysfunction by serial evaluation of circumferential
strain in patients with Duchenne muscular dystrophy. Am J
Cardiol . 2010;105:1451-5.
83. Robb JS and Robb RC. The normal
heart - Anatomy and physiology of the structural units. Am Heart
J . 1942;23:455-467.
84. Torrent-Guasp F, Buckberg GD,
Clemente C, Cox JL, Coghlan HC and Gharib M. The structure and function
of the helical heart and its buttress wrapping. I. The normal
macroscopic structure of the heart. Semin Thorac Cardiovasc Surg .
2001;13:301-19.
85. Buckberg GD, Weisfeldt ML,
Ballester M, Beyar R, Burkhoff D, Coghlan HC, Doyle M, Epstein ND,
Gharib M, Ideker RE, Ingels NB, LeWinter MM, McCulloch AD, Pohost GM,
Reinlib LJ, Sahn DJ, Sopko G, Spinale FG, Spotnitz HM, Torrent-Guasp F
and Shapiro EP. Left ventricular form and function: scientific
priorities and strategic planning for development of new views of
disease. Circulation . 2004;110:e333-6.
86. Helm P, Beg MF, Miller MI and
Winslow RL. Measuring and mapping cardiac fiber and laminar architecture
using diffusion tensor MR imaging. Ann N Y Acad Sci .
2005;1047:296-307.
87. Helm PA, Tseng HJ, Younes L,
McVeigh ER and Winslow RL. Ex vivo 3D diffusion tensor imaging and
quantification of cardiac laminar structure. Magn Reson Med .
2005;54:850-9.
88. Streeter DD, Jr., Spotnitz HM,
Patel DP, Ross J, Jr. and Sonnenblick EH. Fiber orientation in the
canine left ventricle during diastole and systole. Circ Res .
1969;24:339-47.
89. Wu EX, Wu Y, Tang H, Wang J, Yang
J, Ng MC, Yang ES, Chan CW, Zhu S, Lau CP and Tse HF. Study of
myocardial fiber pathway using magnetic resonance diffusion tensor
imaging. Magn Reson Imaging . 2007;25:1048-57.
90. Hor KN, Kissoon N, Mazur W, Gupta
R, Ittenbach RF, Al-Khalidi HR, Cripe LH, Raman SV, Puchalski MD,
Gottliebson WM and Benson DW. Regional circumferential strain is a
biomarker for disease severity in duchenne muscular dystrophy heart
disease: a cross-sectional study. Pediatr Cardiol . 2015;36:111-9.
91. Castillo E, Osman NF, Rosen BD,
El-Shehaby I, Pan L, Jerosch-Herold M, Lai S, Bluemke DA and Lima JA.
Quantitative assessment of regional myocardial function with MR-tagging
in a multi-center study: interobserver and intraobserver agreement of
fast strain analysis with Harmonic Phase (HARP) MRI. J Cardiovasc
Magn Reson . 2005;7:783-91.
92. Almeida AL, Teixido-Tura G, Choi
EY, Opdahl A, Fernandes VR, Wu CO, Bluemke DA and Lima JA. Metabolic
syndrome, strain, and reduced myocardial function: multi-ethnic study of
atherosclerosis. Arquivos brasileiros de cardiologia .
2014;102:327-35.
93. Delgado V, Tops LF, van Bommel
RJ, van der Kley F, Marsan NA, Klautz RJ, Versteegh MI, Holman ER,
Schalij MJ and Bax JJ. Strain analysis in patients with severe aortic
stenosis and preserved left ventricular ejection fraction undergoing
surgical valve replacement. Eur Heart J . 2009;30:3037-47.
94. Helm RH and Lardo AC. Cardiac
magnetic resonance assessment of mechanical dyssynchrony. Current
opinion in cardiology . 2008;23:440-6.
95. Gotte MJ, Germans T, Russel IK,
Zwanenburg JJ, Marcus JT, van Rossum AC and van Veldhuisen DJ.
Myocardial strain and torsion quantified by cardiovascular magnetic
resonance tissue tagging: studies in normal and impaired left
ventricular function. J Am Coll Cardiol . 2006;48:2002-11.
96. Moore CC, Lugo-Olivieri CH,
McVeigh ER and Zerhouni EA. Three-dimensional systolic strain patterns
in the normal human left ventricle: characterization with tagged MR
imaging. Radiology . 2000;214:453-66.
97. Smiseth OA, Torp H, Opdahl A,
Haugaa KH and Urheim S. Myocardial strain imaging: how useful is it in
clinical decision making? Eur Heart J . 2016;37:1196-207.
98. Kuijer JP, Marcus JT, Gotte MJ,
van Rossum AC and Heethaar RM. Three-dimensional myocardial strain
analysis based on short- and long-axis magnetic resonance tagged images
using a 1D displacement field. Magnetic resonance imaging .
2000;18:553-64.
99. Torrent-Guasp F, Kocica MJ, Corno
AF, Komeda M, Carreras-Costa F, Flotats A, Cosin-Aguillar J and Wen H.
Towards new understanding of the heart structure and function. Eur
J Cardiothorac Surg . 2005;27:191-201.
100. Streeter DD, Jr. and Hanna WT.
Engineering mechanics for successive states in canine left ventricular
myocardium. I. Cavity and wall geometry. Circ Res .
1973;33:639-55.
101. Sengupta PP, Korinek J,
Belohlavek M, Narula J, Vannan MA, Jahangir A and Khandheria BK. Left
ventricular structure and function: basic science for cardiac imaging.J Am Coll Cardiol . 2006;48:1988-2001.
102. Osman NF, Kerwin WS, McVeigh ER
and Prince JL. Cardiac motion tracking using CINE harmonic phase (HARP)
magnetic resonance imaging. Magnetic resonance in medicine .
1999;42:1048-60.
103. Osman NF and Prince JL.
Visualizing myocardial function using HARP MRI. Physics in
medicine and biology . 2000;45:1665-82.
104. Valeti VU, Chun W, Potter DD,
Araoz PA, McGee KP, Glockner JF and Christian TF. Myocardial tagging and
strain analysis at 3 Tesla: comparison with 1.5 Tesla imaging.Journal of magnetic resonance imaging : JMRI . 2006;23:477-80.
105. Garot J, Lima JA, Gerber BL,
Sampath S, Wu KC, Bluemke DA, Prince JL and Osman NF. Spatially resolved
imaging of myocardial function with strain-encoded MR: comparison with
delayed contrast-enhanced MR imaging after myocardial infarction.Radiology . 2004;233:596-602.
106. Bogaert J, Bosmans H, Maes A,
Suetens P, Marchal G and Rademakers FE. Remote myocardial dysfunction
after acute anterior myocardial infarction: impact of left ventricular
shape on regional function: a magnetic resonance myocardial tagging
study. J Am Coll Cardiol . 2000;35:1525-34.
107. Hor KN, Hagenbuch SC, Fleck RJ,
Wansapura JP, Mazur W, Benson DW and Gottliebson WM. Serial Evaluation
of Circumferential Strain for Monitoring of Progressive Cardiac
Dysfunction in Duchenne Muscular Dystrophy Patients. Journal of
the American College of Cardiology . 2009;53:A283-A283.
108. Hor KN, Wansapura J, Markham
LW, Mazur W, Cripe LH, Fleck R, Benson DW and Gottliebson WM.
Circumferential strain analysis identifies strata of cardiomyopathy in
Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.J Am Coll Cardiol . 2009;53:1204-10.
109. Wesbey G, Higgins CB, Lanzer P,
Botvinick E and Lipton MJ. Imaging and characterization of acute
myocardial infarction in vivo by gated nuclear magnetic resonance.Circulation . 1984;69:125-30.
110. Wesbey GE, Higgins CB, McNamara
MT, Engelstad BL, Lipton MJ, Sievers R, Ehman RL, Lovin J and Brasch RC.
Effect of gadolinium-DTPA on the magnetic relaxation times of normal and
infarcted myocardium. Radiology . 1984;153:165-9.
111. Tscholakoff D, Higgins CB,
Sechtem U and McNamara MT. Occlusive and reperfused myocardial infarcts:
effect of Gd-DTPA on ECG-gated MR imaging. Radiology .
1986;160:515-9.
112. McNamara MT, Higgins CB, Ehman
RL, Revel D, Sievers R and Brasch RC. Acute myocardial ischemia:
magnetic resonance contrast enhancement with gadolinium-DTPA.Radiology . 1984;153:157-63.
113. McNamara MT, Tscholakoff D,
Revel D, Soulen R, Schechtmann N, Botvinick E and Higgins CB.
Differentiation of reversible and irreversible myocardial injury by MR
imaging with and without gadolinium-DTPA. Radiology .
1986;158:765-9.
114. Saeed M, Wendland MF, Takehara
Y and Higgins CB. Reversible and irreversible injury in the reperfused
myocardium: differentiation with contrast material-enhanced MR imaging.Radiology . 1990;175:633-7.
115. Eichstaedt HW, Felix R,
Dougherty FC, Langer M, Rutsch W and Schmutzler H. Magnetic resonance
imaging (MRI) in different stages of myocardial infarction using the
contrast agent gadolinium-DTPA. Clinical cardiology .
1986;9:527-35.
116. Kim RJ, Albert TS, Wible JH,
Elliott MD, Allen JC, Lee JC, Parker M, Napoli A and Judd RM.
Performance of delayed-enhancement magnetic resonance imaging with
gadoversetamide contrast for the detection and assessment of myocardial
infarction: an international, multicenter, double-blinded, randomized
trial. Circulation . 2008;117:629-37.
117. Kim RJ, Wu E, Rafael A, Chen
EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO and Judd RM. The use of
contrast-enhanced magnetic resonance imaging to identify reversible
myocardial dysfunction. N Engl J Med . 2000;343:1445-53.
118. Simonetti OP, Kim RJ, Fieno DS,
Hillenbrand HB, Wu E, Bundy JM, Finn JP and Judd RM. An improved MR
imaging technique for the visualization of myocardial infarction.Radiology . 2001;218:215-23.
119. Choi KM, Kim RJ, Gubernikoff G,
Vargas JD, Parker M and Judd RM. Transmural extent of acute myocardial
infarction predicts long-term improvement in contractile function.Circulation . 2001;104:1101-7.
120. Fieno DS, Hillenbrand HB,
Rehwald WG, Harris KR, Decker RS, Parker MA, Klocke FJ, Kim RJ and Judd
RM. Infarct resorption, compensatory hypertrophy, and differing patterns
of ventricular remodeling following myocardial infarctions of varying
size. J Am Coll Cardiol . 2004;43:2124-31.
121. Hillenbrand HB, Kim RJ, Parker
MA, Fieno DS and Judd RM. Early assessment of myocardial salvage by
contrast-enhanced magnetic resonance imaging. Circulation .
2000;102:1678-83.
122. Lima JA, Judd RM, Bazille A,
Schulman SP, Atalar E and Zerhouni EA. Regional heterogeneity of human
myocardial infarcts demonstrated by contrast-enhanced MRI. Potential
mechanisms. Circulation . 1995;92:1117-25.
123. Ramani K, Judd RM, Holly TA,
Parrish TB, Rigolin VH, Parker MA, Callahan C, Fitzgerald SW, Bonow RO
and Klocke FJ. Contrast magnetic resonance imaging in the assessment of
myocardial viability in patients with stable coronary artery disease and
left ventricular dysfunction. Circulation . 1998;98:2687-94.
124. Ingkanisorn WP, Rhoads KL,
Aletras AH, Kellman P and Arai AE. Gadolinium delayed enhancement
cardiovascular magnetic resonance correlates with clinical measures of
myocardial infarction. J Am Coll Cardiol . 2004;43:2253-9.
125. Bello D, Shah DJ, Farah GM, Di
Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM,
Gheorghiade M and Kim RJ. Gadolinium cardiovascular magnetic resonance
predicts reversible myocardial dysfunction and remodeling in patients
with heart failure undergoing beta-blocker therapy. Circulation .
2003;108:1945-53.
126. McCrohon JA, Moon JC, Prasad
SK, McKenna WJ, Lorenz CH, Coats AJ and Pennell DJ. Differentiation of
heart failure related to dilated cardiomyopathy and coronary artery
disease using gadolinium-enhanced cardiovascular magnetic resonance.Circulation . 2003;108:54-9.
127. Rochitte CE, Oliveira PF,
Andrade JM, Ianni BM, Parga JR, Avila LF, Kalil-Filho R, Mady C,
Meneghetti JC, Lima JA and Ramires JA. Myocardial delayed enhancement by
magnetic resonance imaging in patients with Chagas’ disease: a marker of
disease severity. J Am Coll Cardiol . 2005;46:1553-8.
128. Ryan TD, Taylor MD, Mazur W,
Cripe LH, Pratt J, King EC, Lao K, Grenier MA, Jefferies JL, Benson DW
and Hor KN. Abnormal circumferential strain is present in young Duchenne
muscular dystrophy patients. Pediatr Cardiol . 2013;34:1159-65.
129. Raman SV, Hor KN, Mazur W,
Halnon NJ, Kissel JT, He X, Tran T, Smart S, McCarthy B, Taylor MD,
Jefferies JL, Rafael-Fortney JA, Lowe J, Roble SL and Cripe LH.
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a
randomised, double-blind, placebo-controlled trial. Lancet
Neurol . 2015;14:153-61.
130. Raman SV, Hor KN, Mazur W, He
X, Kissel JT, Smart S, McCarthy B, Roble SL and Cripe LH. Eplerenone for
early cardiomyopathy in Duchenne muscular dystrophy: results of a
two-year open-label extension trial. Orphanet J Rare Dis .
2017;12:39.
131. Raman SV, Hor KN, Mazur W,
Cardona A, He X, Halnon N, Markham L, Soslow JH, Puchalski MD, Auerbach
SR, Truong U, Smart S, McCarthy B, Saeed IM, Statland JM, Kissel JT and
Cripe LH. Stabilization of Early Duchenne Cardiomyopathy With
Aldosterone Inhibition: Results of the Multicenter AIDMD Trial. J
Am Heart Assoc . 2019;8:e013501.
132. Kellman P, Bandettini WP,
Mancini C, Hammer-Hansen S, Hansen MS and Arai AE. Characterization of
myocardial T1-mapping bias caused by intramyocardial fat in inversion
recovery and saturation recovery techniques. J Cardiovasc Magn
Reson . 2015;17:33.
133. Kellman P and Hansen MS.
T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn
Reson . 2014;16:2.
134. Lundin M, Sorensson P,
Vishnevskaya L, Maret E, Kellman P, Sigfridsson A and Ugander M.
Detection of myocarditis using T1 and ECV mapping is not improved by
early compared to late post-contrast imaging. Clin Physiol Funct
Imaging . 2019;39:384-392.
135. Messroghli DR, Radjenovic A,
Kozerke S, Higgins DM, Sivananthan MU and Ridgway JP. Modified
Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of
the heart. Magn Reson Med . 2004;52:141-6.
136. Messroghli DR, Greiser A,
Frohlich M, Dietz R and Schulz-Menger J. Optimization and validation of
a fully-integrated pulse sequence for modified look-locker
inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson
Imaging . 2007;26:1081-6.
137. Fontana M, White SK, Banypersad
SM, Sado DM, Maestrini V, Flett AS, Piechnik SK, Neubauer S, Roberts N
and Moon JC. Comparison of T1 mapping techniques for ECV quantification.
Histological validation and reproducibility of ShMOLLI versus
multibreath-hold T1 quantification equilibrium contrast CMR. J
Cardiovasc Magn Reson . 2012;14:88.
138. Flett AS, Hayward MP, Ashworth
MT, Hansen MS, Taylor AM, Elliott PM, McGregor C and Moon JC.
Equilibrium contrast cardiovascular magnetic resonance for the
measurement of diffuse myocardial fibrosis: preliminary validation in
humans. Circulation . 2010;122:138-44.
139. Soslow JH, Damon BM, Saville
BR, Lu Z, Burnette WB, Lawson MA, Parra DA, Sawyer DB and Markham LW.
Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy
using cardiac magnetic resonance imaging. Pediatr Cardiol .
2015;36:49-56.
140. Soslow JH, Damon SM, Crum K,
Lawson MA, Slaughter JC, Xu M, Arai AE, Sawyer DB, Parra DA, Damon BM
and Markham LW. Increased myocardial native T1 and extracellular volume
in patients with Duchenne muscular dystrophy. J Cardiovasc Magn
Reson . 2016;18:5.
141. Dickstein K, Cohen-Solal A,
Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A,
van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M,
Priori SG, Swedberg K and Guidelines ESCCfP. ESC Guidelines for the
diagnosis and treatment of acute and chronic heart failure 2008: the
Task Force for the Diagnosis and Treatment of Acute and Chronic Heart
Failure 2008 of the European Society of Cardiology. Developed in
collaboration with the Heart Failure Association of the ESC (HFA) and
endorsed by the European Society of Intensive Care Medicine (ESICM).Eur Heart J . 2008;29:2388-442.
142. Fonseca C. Diagnosis of heart
failure in primary care. Heart Fail Rev . 2006;11:95-107.
143. Davie AP, Francis CM, Caruana
L, Sutherland GR and McMurray JJ. Assessing diagnosis in heart failure:
which features are any use? QJM . 1997;90:335-9.
144. Oudejans I, Mosterd A, Bloemen
JA, Valk MJ, van Velzen E, Wielders JP, Zuithoff NP, Rutten FH and Hoes
AW. Clinical evaluation of geriatric outpatients with suspected heart
failure: value of symptoms, signs, and additional tests. Eur J
Heart Fail . 2011;13:518-27.
145. Chen J, Normand SL, Wang Y and
Krumholz HM. National and regional trends in heart failure
hospitalization and mortality rates for Medicare beneficiaries,
1998-2008. JAMA . 2011;306:1669-78.
146. Mant J, Doust J, Roalfe A,
Barton P, Cowie MR, Glasziou P, Mant D, McManus RJ, Holder R, Deeks J,
Fletcher K, Qume M, Sohanpal S, Sanders S and Hobbs FD. Systematic
review and individual patient data meta-analysis of diagnosis of heart
failure, with modelling of implications of different diagnostic
strategies in primary care. Health Technol Assess . 2009;13:1-207,
iii.
147. Rutten FH, Moons KG, Cramer MJ,
Grobbee DE, Zuithoff NP, Lammers JW and Hoes AW. Recognising heart
failure in elderly patients with stable chronic obstructive pulmonary
disease in primary care: cross sectional diagnostic study. BMJ .
2005;331:1379.
148. Daniels LB, Clopton P, Bhalla
V, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T,
Storrow AB, Abraham WT, Wu AHB, Steg PG, Westheim A, Knudsen CW, Perez
A, Kazanegra R, Herrmann HC, McCullough PA and Maisel AS. How obesity
affects the cut-points for B-type natriuretic peptide in the diagnosis
of acute heart failure: Results from the Breathing Not Properly
Multinational Study. Am Heart J . 2006;151:999-1005.
149. Hawkins NM, Petrie MC, Jhund
PS, Chalmers GW, Dunn FG and McMurray JJ. Heart failure and chronic
obstructive pulmonary disease: diagnostic pitfalls and epidemiology.Eur J Heart Fail . 2009;11:130-9.
150. Hawkins NM, Virani S and Ceconi
C. Heart failure and chronic obstructive pulmonary disease: the
challenges facing physicians and health services. Eur Heart J .
2013;34:2795-803.
151. Shih JA, Folch A and Wong BL.
Duchenne Muscular Dystrophy: the Heart of the Matter. Curr Heart
Fail Rep . 2020;17:57-66.
152. Hor KN, Mazur W, Taylor MD,
Al-Khalidi HR, Cripe LH, Jefferies JL, Raman SV, Chung ES, Kinnett KJ,
Williams K, Gottliebson WM and Benson DW. Effects of steroids and
angiotensin converting enzyme inhibition on circumferential strain in
boys with Duchenne muscular dystrophy: a cross-sectional and
longitudinal study utilizing cardiovascular magnetic resonance. J
Cardiovasc Magn R . 2011;13.
153. Raman SV, Hor KN, Mazur W,
Halnon NJ, Kissel JT, He X, Tran T, Smart S, McCarthy B, Taylor MD,
Jefferies JL, Rafael-Fortney JA, Lowe J, Roble SL and Cripe LH.
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a
randomised, double-blind, placebo-controlled trial. Lancet
Neurol . 2015;14:153-161.
154. Soslow JH, Damon BM, Saville
BR, Lu Z, Burnette WB, Lawson MA, Parra DA, Sawyer DB and Markham LW.
Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy
using cardiac magnetic resonance imaging. Pediatr Cardiol .
2015;36:49-56.
155. Soslow JH, Damon SM, Crum K,
Lawson MA, Slaughter JC, Xu M, Arai AE, Sawyer DB, Parra DA, Damon BM
and Markham LW. Increased myocardial native T1 and extracellular volume
in patients with Duchenne muscular dystrophy. Journal of
cardiovascular magnetic resonance : official journal of the Society for
Cardiovascular Magnetic Resonance . 2016;18:5.
156. Wittlieb-Weber CA, Knecht KR,
Villa CR, Cunningham C, Conway J, Bock MJ, Gambetta KE, Lal AK,
Schumacher KR, Law SP, Deshpande SR, West SC, Friedland-Little JM,
Lytrivi ID, McCulloch MA, Butts RJ, Weber DR and Johnson JN. Risk
Factors for Cardiac and Non-cardiac Causes of Death in Males with
Duchenne Muscular Dystrophy. Pediatr Cardiol . 2020;41:764-771.